WE vs Re
Price, ratings, monetisation and update history for both apps, side by side β with what reviewers say about each.
WE
Read full descriptionHide full description
The WE-ACT app is designed to promote better communication between cancer patients and their employers and between cancer patients and their healthcare teams. This app contains helpful information for cancer patients to use during and after treatment. Victoria Blinder, MD, MSc, is a board certified medical oncologist at Memorial Sloan Kettering Cancer Center with a practice that is dedicated to the treatment of patients with cancer. Her research focuses on understanding and addressing disparities in cancer outcomes. She is the primary investigator of the WE-ACT Study, which tests an early version of this mobile health app designed to help cancer patients keep their jobs during and after treatment. Medical Disclosure: This mobile application (βAppβ) is operated by Memorial Sloan Kettering Cancer Center (βMSKβ) and is intended only for users who consented to take part in the research study named Talking to Employers and Medical Staff About Work (WE-ACT). THIS APP IS NOT TO BE USED AS A SUBSTITUTE FOR MEDICAL ADVICE, DIAGNOSIS, OR TREATMENT OF ANY HEALTH CONDITION OR PROBLEM. ANY QUESTIONS REGARDING YOUR OWN HEALTH SHOULD BE ADDRESSED TO YOUR OWN PHYSICIAN OR OTHER HEALTHCARE PROVIDER. The App may contain links to external websites or mobile applications that are not owned or operated by MSK (the βExternal Contentβ). MSK does not control External Content and we are not responsible for the content or performance of those sites. A link to External Content does not imply any agreement with or endorsement of the External Content or any association with the owner or operators of the External Content. You are responsible for viewing and abiding by the terms and conditions of use and the privacy statements of the External Content.
Re
Read full descriptionHide full description
On discussion forums, users can share perspectives, thoughts on cancer breakthroughs, and strategies theyβve learned. For individual discussions, direct messages are available. Users can access linked resources, recommended books, and a form to share their own books. Discussion forums include: - The General Discussion, the all-inclusive place to share experiences, questions, and more - Cancer Breakthroughs, for an optimistic discussion of the latest advancements in cancer medicine - Treatments and Side Effects, a place for support regarding treatments, side-effects, and strategies - Mental Health and Support, for discussing emotional wellbeing and support Privacy Policy: https://docs.google.com/document/d/e/2PACX-1vSdaOUt22OZz_Lqpi2Jl0JLYYCc4b65rmzgLJk7mttG1cCj9llp9FkBMC45O8nnsPnxqEv8T1SmKgZv/pub Get Support: https://forms.gle/EU17u21QWQ2Pc8vh7
Screenshots
Verdict
WE and Re are too close to call on the numbers: across 5 compared parameters β price, ads, in-app purchases and device support among them β neither pulls far enough ahead to decide it. What separates them is feature set and interface, not measurable difference.
Scored on Price Β· Rating Β· Positive reviews Β· Number of ratings Β· Update frequency Β· Ads Β· In-app purchases Β· Monetization Β· Best chart rank Β· Devices Β· Requires iOS
Both are free to download. Neither carries in-app purchases, so what you see is what you pay.
| Parameter | WE | Re |
|---|---|---|
| Price | Free | Free |
| Update frequency | Every 6 months | β |
| Ads | No | No |
| In-app purchases | No | No |
| Devices | iPhone, iPad, iPod β better | iPhone, iPad |
| Requires iOS | 15.6 β better | 16.4 |
| Further details β not scored | ||
| Size | 59 MB | 41 MB |
| Age rating | 17+ | 17+ |
| Developer | Memorial Sloan Kettering Cancer Center | Malvinia Sambursky |
In-app purchases
WE
No in-app purchases
Re
No in-app purchases







